Weekly Market Recap – Week Ending November 28, 2025 Market action during Thanksgiving week delivered a broad-based rebound across U.S. equities. Nearly every ETF in our coverage list finished higher, led by strong gains in small caps (VB +3.64%), consumer discretionary (XLY +3.48%), and materials (XLB +3.33%). Large-cap growth also participated, with QQQM rising 2.31% … Read more
Weekly Market Recap – Week Ending November 21, 2025 The week closed with a mixed tone as sector performance varied sharply across the equity landscape. Technology and communication services led the downside, while defensive sectors such as utilities and consumer staples provided modest stability. Meanwhile, select international and emerging-market names delivered strong 30-day momentum, reflecting … Read more
Weekly Market Recap – Week Ending November 14, 2025 The past week saw a clear defensive tilt across major ETFs, with only a handful of pockets showing resilience. Utilities, consumer staples, and select dividend strategies managed modest gains, while growth-heavy benchmarks such as QQQM and technology-sector ETFs slipped more than 2%. At the individual-stock level, … Read more
ValuEngine Market Valuation update for the week of November 15, 2019. Strong Buy pick is ticker TEVA ( Teva Pharmaceutical Industries Ltd ). As always all stock, sector, and industry valuations and forecast target prices have been updated with current data. Read on for the full update. www.ValuEngine.com to log in, or free two-week full trial. … Read more
This week, we provide top-five ranked VE data for our Medical Sector stocks, take a look at General Electric $GE, and provide a free download link for our stock report on the company. VALUATION WATCH: Overvalued stocks now make up 43.61% of our stocks assigned a valuation and 17.94% of those equities are calculated to … Read more
This week, we provide top-five ranked VE data for our Basic Materials Sector stocks. We take a look at our latest data on Chemours Company $CC and provide a free download link for our stock report on the company. VALUATION WATCH: Overvalued stocks now make up 61.86% of our stocks assigned a valuation and 26.49% … Read more
This week, we provide top-five ranked VE data for our Medical Sector stocks. We take a look at our latest data on JPMorgan Chase $JPM and provide a free download link for our stock report on the company. Because overvaluation has crept up again, we now have another Valuation Watch. VALUATION WATCH: Overvalued stocks now … Read more